Close Menu

NEW YORK (GenomeWeb) – Biocept today priced its public offering of 6.25 million shares of its common stock and warrants to purchase up to 6.25 million shares of the common stock.

Each share of stock is being sold with one warrant to purchase one share of common stock at a combined price of $1.20 per share and warrant. Gross proceeds from the offering are expected to be about $7.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.